Diagnostics Focus

Table of Contents

Company Activities

• Activities in Brief
• Sphere Medical raises funds through share issue
• Fujirebio acquires CanAg Diagnostics
• Quest makes US$185 million offer to acquire Focus Diagnostics
• AMDL provides update on Chinese acquisition
• Inverness closes subsidiaries and transfers production to key sites in the UK and China
• Asuragen raises funds to aid cancer diagnostic programme

Key alliances

• Utek and AMI enter strategic pact
• Acrongenomics enters joint development pact with Molecular Vision for POC solutions
• Pheromone to proceed with joint venture to develop diabetes treatment
• BioMag selects advisor to manage clinical trials in Thailand
• Trinity Biotech increases share in coagulation market with bioMérieux asset purchase
• Gen-Probe and DiagnoCure provide update on PCA3 collaboration
• FIND and Cepheid work together to develop rapid TB test
• Trinity Biotech participates in supply programme for rapid HIV test
• Alpine Biomed and Medtronic co-develop gastro-enterology diagnostics
• UCDHSC and Source MDx join forces to develop molecular diagnostics for melanoma and psoriasis
• Rosetta and US Genomics work together to develop early detection test for lung cancer
• Xenomics licenses DNA marker for AML
• Atherotech and Source Scientific collaborate to manufacture VAP cholesterol test equipment

Product news

• American Bio Medica gains FDA approval for Rapid TOX
• CE mark for Perceptronix' lung cancer test
• Axis-Shield launches D-dimer test for DVT and PE
• FDA gives green light for Chembio' s rapid HIV tests
• TomTec unveils 4D imaging software for RV diagnostics
• IBL unveils ERC/Mesothelin Expression analysis kit
• OXIS introduces new oncology detection product for HMGA2
• CE marks sought for Zonda tests

Research and development

• Positive results extracted from multi-centre ovarian cancer biomarker validation study
• EFP reports successful results against H9N2 avian influenza strain
• PrecisionMed and Dx Innovations file patent for neuropsychiatric disease diagnostic procedures
• Study confirms sensitivity of Digene' s HPV test
• Positive results released in development of genomic test for colon cancer
• Bayer' s Serum HER-2/neu test predicts clinical outcome to trastuzumab-based therapy in MBC patients
• Colorectal biomarker results verified by Miraculins
• Investigators report benefits of Matritech' s NMP22 BladderChek test at AUA meeting
• diaDexus gains US patent for PLAC test
• BioWarn' s SmartSense system detects avian influenza instantaneously
• MacroArray presents data on diagnostic test for PIN at ASCO
• Paradigm Spine funds trials for diagnostic test to prevent idiopathic scoliosis
• Chinese scientists report on the value of DR-70 for oral cancer patient screening
• Study uncovers high sensitivity rate for EXACT' s stool DNA colorectal cancer screening technology
• Study suggests GlycoMark blood test has a role to playe in diabetes care
• CS-Keys joins fight against breast cancer with new diagnostic tool
• Mayo Clinic report underlines need for more effective diagnosis of patients with suspected pancreatic cancer
• Study finds Glycominds' IBDX biomarkers predict need for surgery in Crohn' s disease patients
• New biomarkers may aid management of prostate cancer

Other News

• Dako and Ventana resolve patent litigation
• Intact Medical' s BLES qualifies for higher reimbursement rate
• Vapaatalo elected Vice Chairman of the Board of Directors of Orion
• Digene' s CEO announces intention to retire
• Upstream Biosciences adds to its scientific advisory board
• OraSure appoints former Chiron executive

Conference Listings

Company index